VRDNNasdaq United States
Market cap
$2.432 B
$23.59 +4.80%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
-$342.6M
Loss-making
Shares outstanding
113,292,269
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Viridian Therapeutics, Inc.\DE are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.